Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7754539
[patent_doc_number] => 20120027726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'Methods for Distributing High Levels of Therapeutic Agent Throughout the Cortex to Treat Neurological Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/146640
[patent_app_country] => US
[patent_app_date] => 2010-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20270
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027726.pdf
[firstpage_image] =>[orig_patent_app_number] => 13146640
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/146640 | Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders | Jan 28, 2010 | Issued |
Array
(
[id] => 6431314
[patent_doc_number] => 20100143388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Antibody Composition-Producing Cell'
[patent_app_type] => utility
[patent_app_number] => 12/628083
[patent_app_country] => US
[patent_app_date] => 2009-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 77425
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143388.pdf
[firstpage_image] =>[orig_patent_app_number] => 12628083
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/628083 | Antibody Composition-Producing Cell | Nov 29, 2009 | Abandoned |
Array
(
[id] => 6314049
[patent_doc_number] => 20100111924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Chromosomal Modification Involving the Induction of Double-Stranded DNA Cleavage and Homologous Recombination at the Cleavage Site'
[patent_app_type] => utility
[patent_app_number] => 12/607502
[patent_app_country] => US
[patent_app_date] => 2009-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8929
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20100111924.pdf
[firstpage_image] =>[orig_patent_app_number] => 12607502
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/607502 | Chromosomal Modification Involving the Induction of Double-Stranded DNA Cleavage and Homologous Recombination at the Cleavage Site | Oct 27, 2009 | Abandoned |
Array
(
[id] => 7719887
[patent_doc_number] => 20120009222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'MODULATION OF THE IMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 13/126260
[patent_app_country] => US
[patent_app_date] => 2009-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 32391
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20120009222.pdf
[firstpage_image] =>[orig_patent_app_number] => 13126260
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/126260 | MODULATION OF THE IMMUNE RESPONSE | Oct 26, 2009 | Abandoned |
Array
(
[id] => 7754718
[patent_doc_number] => 20120027807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'TISSUE ENGINEERED MYOCARDIUM AND METHODS OF PRODUCTION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/121279
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 63697
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027807.pdf
[firstpage_image] =>[orig_patent_app_number] => 13121279
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/121279 | TISSUE ENGINEERED MYOCARDIUM AND METHODS OF PRODUCTION AND USES THEREOF | Oct 8, 2009 | Abandoned |
Array
(
[id] => 6220668
[patent_doc_number] => 20100055763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'METHOD FOR THE PRODUCTION AND PURIFICATION OF RETROVIRAL VECTORS'
[patent_app_type] => utility
[patent_app_number] => 12/572943
[patent_app_country] => US
[patent_app_date] => 2009-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 32623
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055763.pdf
[firstpage_image] =>[orig_patent_app_number] => 12572943
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/572943 | METHOD FOR THE PRODUCTION AND PURIFICATION OF RETROVIRAL VECTORS | Oct 1, 2009 | Abandoned |
Array
(
[id] => 7680706
[patent_doc_number] => 20100105880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'PURIFICATION OF CARBON NANOTUBES VIA BIOMOLECULES'
[patent_app_type] => utility
[patent_app_number] => 12/571098
[patent_app_country] => US
[patent_app_date] => 2009-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 3086
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105880.pdf
[firstpage_image] =>[orig_patent_app_number] => 12571098
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/571098 | PURIFICATION OF CARBON NANOTUBES VIA BIOMOLECULES | Sep 29, 2009 | Abandoned |
Array
(
[id] => 6230383
[patent_doc_number] => 20100184226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'MEDIA CONDITIONING FOR IMPROVING GENE DELIVERY EFFICIENCY TO DIFFERENTIATING EMBRYONIC STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/564903
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7571
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184226.pdf
[firstpage_image] =>[orig_patent_app_number] => 12564903
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564903 | Media conditioning for improving gene delivery efficiency to differentiating embryonic stem cells | Sep 21, 2009 | Issued |
Array
(
[id] => 6302236
[patent_doc_number] => 20100068183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Methods of treating lysosomal storage related diseases by gene therapy'
[patent_app_type] => utility
[patent_app_number] => 12/586342
[patent_app_country] => US
[patent_app_date] => 2009-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26218
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068183.pdf
[firstpage_image] =>[orig_patent_app_number] => 12586342
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/586342 | Methods of treating lysosomal storage related diseases by gene therapy | Sep 20, 2009 | Abandoned |
Array
(
[id] => 6220073
[patent_doc_number] => 20100055168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'CATIONIC LIPIDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/557188
[patent_app_country] => US
[patent_app_date] => 2009-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 42761
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055168.pdf
[firstpage_image] =>[orig_patent_app_number] => 12557188
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/557188 | CATIONIC LIPIDS AND USES THEREOF | Sep 9, 2009 | Abandoned |
Array
(
[id] => 8538192
[patent_doc_number] => 08313913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-20
[patent_title] => 'Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIa'
[patent_app_type] => utility
[patent_app_number] => 12/550160
[patent_app_country] => US
[patent_app_date] => 2009-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 41
[patent_no_of_words] => 71833
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12550160
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/550160 | Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIa | Aug 27, 2009 | Issued |
Array
(
[id] => 6486870
[patent_doc_number] => 20100093094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'TRIAZINE DENDRIMERS AND METHODS OF MAKING AND USING THE SAME FOR NUCLEIC ACID TRANSPORT'
[patent_app_type] => utility
[patent_app_number] => 12/549182
[patent_app_country] => US
[patent_app_date] => 2009-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 4673
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093094.pdf
[firstpage_image] =>[orig_patent_app_number] => 12549182
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/549182 | TRIAZINE DENDRIMERS AND METHODS OF MAKING AND USING THE SAME FOR NUCLEIC ACID TRANSPORT | Aug 26, 2009 | Abandoned |
Array
(
[id] => 6478177
[patent_doc_number] => 20100092395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'ACOUSTICALLY DELIVERING METHODS AND COMPOSITONS FOR REMOTE TREATMENT OF A TUMOR'
[patent_app_type] => utility
[patent_app_number] => 12/541965
[patent_app_country] => US
[patent_app_date] => 2009-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6836
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20100092395.pdf
[firstpage_image] =>[orig_patent_app_number] => 12541965
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/541965 | ACOUSTICALLY DELIVERING METHODS AND COMPOSITONS FOR REMOTE TREATMENT OF A TUMOR | Aug 15, 2009 | Abandoned |
Array
(
[id] => 9951246
[patent_doc_number] => 09000033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Composition for improving skin condition and appearance'
[patent_app_type] => utility
[patent_app_number] => 12/512368
[patent_app_country] => US
[patent_app_date] => 2009-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 8409
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12512368
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/512368 | Composition for improving skin condition and appearance | Jul 29, 2009 | Issued |
Array
(
[id] => 6094717
[patent_doc_number] => 20110219462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'G-Protein Coupled Receptor 30 (GPR30) transgenic animals as a model for cardiovascular diseases'
[patent_app_type] => utility
[patent_app_number] => 13/054509
[patent_app_country] => US
[patent_app_date] => 2009-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 22612
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20110219462.pdf
[firstpage_image] =>[orig_patent_app_number] => 13054509
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054509 | G-Protein Coupled Receptor 30 (GPR30) transgenic animals as a model for cardiovascular diseases | Jul 1, 2009 | Abandoned |
Array
(
[id] => 6218381
[patent_doc_number] => 20110138488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'DEFICIENCY IN THE HISTONE DEMETHYLASE JHDM2A RESULTS IN IMPAIRED ENERGY EXPENDITURE AND OBESITY'
[patent_app_type] => utility
[patent_app_number] => 12/999059
[patent_app_country] => US
[patent_app_date] => 2009-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 21365
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20110138488.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999059
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999059 | DEFICIENCY IN THE HISTONE DEMETHYLASE JHDM2A RESULTS IN IMPAIRED ENERGY EXPENDITURE AND OBESITY | Jun 22, 2009 | Abandoned |
Array
(
[id] => 5943620
[patent_doc_number] => 20110104240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections'
[patent_app_type] => utility
[patent_app_number] => 13/000555
[patent_app_country] => US
[patent_app_date] => 2009-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19266
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104240.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000555
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000555 | Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections | Jun 22, 2009 | Abandoned |
Array
(
[id] => 6167905
[patent_doc_number] => 20110162092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'COMPOSITION COMPRISED OF AKAP12 AND USES OF AKAP12 MUTANT ZEBRAFISH AS AN ANIMAL MODEL'
[patent_app_type] => utility
[patent_app_number] => 12/997653
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 8723
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20110162092.pdf
[firstpage_image] =>[orig_patent_app_number] => 12997653
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997653 | COMPOSITION COMPRISED OF AKAP12 AND USES OF AKAP12 MUTANT ZEBRAFISH AS AN ANIMAL MODEL | Jun 11, 2009 | Abandoned |
Array
(
[id] => 10176276
[patent_doc_number] => 09206471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Self-replicating materials'
[patent_app_type] => utility
[patent_app_number] => 12/482823
[patent_app_country] => US
[patent_app_date] => 2009-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 62
[patent_no_of_words] => 14760
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12482823
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/482823 | Self-replicating materials | Jun 10, 2009 | Issued |
Array
(
[id] => 8363696
[patent_doc_number] => 08252761
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-28
[patent_title] => 'Method of increasing murine ES cell differentiation with PCL2'
[patent_app_type] => utility
[patent_app_number] => 12/457407
[patent_app_country] => US
[patent_app_date] => 2009-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 18
[patent_no_of_words] => 9929
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12457407
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/457407 | Method of increasing murine ES cell differentiation with PCL2 | Jun 9, 2009 | Issued |